Pulmonx Corporation

LUNG· NASDAQ· Health Care· Health Care Equipment & Services

$2.12+30.06%

2026-08-03

Financials

Valuation Metrics

Pulmonx Corporation's Market Cap is $90M. At end of 2025 it was $92M. Ranked #3089 of 3,111 in US market (top 99%), #1425 of 1,445 on NASDAQ (top 99%), #203 of 206 in Health Care Equipment & Services (top 99%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$90M	US#3,089/3,111 Sec#203/206
Revenue	$89M	US#2,810/3,111 Sec#193/206
Net Income	$-53M	US—/3,111 Sec—/206
Total Assets	$120M	US#3,035/3,111 Sec#200/206
Net Assets	$46M	US#2,948/3,111 Sec#195/206
Value
P/B	1.96x	US#836/3,111 Sec#48/206
P/S	1.01x	US#510/3,111 Sec#39/206
FCF Yield	-32.90%	US—/3,111 Sec—/206
Profitability
ROE	-116.28%	US#2,870/3,111 Sec#185/206
ROA	-44.35%	US#2,952/3,111 Sec#197/206
Op. Margin	-58.79%	US#2,786/3,111 Sec#189/206
Revenue Growth	-8.66%	US#2,645/3,111 Sec#189/206
Financial Health
Debt Ratio	162.16%	US#1,581/3,111 Sec#142/206
Total Debt	$56M	US#2,548/3,111 Sec#148/206
FCF	$-29M	US#2,414/3,111 Sec#171/206
Cash	$62M	US#2,504/3,111 Sec#163/206
Current Ratio	4.91x	US#478/3,111 Sec#45/206
Performance
1Y Return	31.68%	US#2,356/3,111 Sec#155/206
1M Return	52.52%	US#436/3,111 Sec#41/206
From 52W High	-26.64%	US#2,596/3,111 Sec#170/206
1Y MDD	-69.05%	US#2,904/3,111 Sec#185/206
Trading
Volume	2,177,414 shares	US#963/3,111 Sec#59/206
Trading Value	$4M	US#2,821/3,111 Sec#183/206
Per Share
EPS	$-1.30	US—/3,111 Sec—/206
BPS	$1.31	US#2,591/3,111 Sec#177/206